Although the VEGF mRNA and HIF-1α mRNA level in OSA group tended to be reduced by 4 weeks of OSA treatment as compared with that in control group, there was no significant difference (Table 3). This evidence concerns the gene HIF1A and obstructive sleep apnea syndrome.